Start: July 2017
End: December 31, 2022
Noninvasive retinal imaging may be able to identify biomarkers, or signs within the body, associated with mild cognitive impairment (MCI), Alzheimer's disease, and Parkinson's Disease (PD), or other neurodegenerative disease. In this study, researchers are investigating the optical coherence tomography angiography (OCTA) imaging technique as a potential screening tool. Participants will undergo noninvasive eye scans with OCTA. Researchers will use the scans to assess the structure and function of retinal blood vessels in people with these diseases compared to those without.
Minimum Age: 18 Years
Maximum Age: N/A
Note: If two eyes satisfy the inclusion criteria, both eyes will be included in the study. If one eye satisfies the inclusion criteria, the eye that qualifies will be included in the study.
Contact study personnel listed either under the general study contact or the location nearest you.
Duke University Medical Center
Durham, NC 27705
RecruitingDilraj Grewal, MD
Lead: Duke University
Source: ClinicalTrials.gov ID: NCT03233646